HARROW INC.

- USD (-)

- 15 min delayed data - NASDAQ Stocks

Open:	-
Change:	-
Volume:	-

Low:	-
High:	-
High / Low range:	-

Type:	Stocks
Ticker:	HROW
ISIN:

Overview
Quotes
Chart
Signals
News
Analyses
Warrants
Profile
Wall

HARROW INC. overview

> News GlobeNewsWire published a news.

Melt Pharmaceuticals Completes Phase 1 Study for Sublingual, Non-Opioid Pain and Sedation Drug Candidate • • GlobeNewsWire • Stocks • More HARROW INC. news...

BOSTON, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing first-in-class medicines for sedation and analgesia, announced results from its MELT Phase 1 study, a comparative bioavailability study with the objective of characterizing the pharmacokinetic parameters of two dosage strengths of the patented MELT technology (midazolam 3 mg/ketamine 25 mg and midazolam 6 mg/ketamine 50 mg) in healthy volunteers and comparing it to...

Thank you Chart

Load more content

Market scanning tools

Patterns
Candlesticks
Indicators

See all Signals

Statistics

Analyses : 2
Followers : 0